PureTech Health has obtained approval from the US Food and Drug Administration (FDA) for KarXT to treat schizophrenia in ...

The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...

A year of recovery After a challenging period, 2024 has seen a more positive backdrop emerge for the biotechnology sector. In ...

The FDA approved a new drug for schizophrenia. Discrimination is stressing Chinese Americans and damaging their mental health.

Modalis Therapeutics has been awarded a rare paediatric disease designation by the US Food and Drug Administration (FDA) for ...

SK pharmteco, a contract development and manufacturing organisation, has announced an investment of $260m to expand its small ...

In the year’s fourth-largest deal, Prime Medicine Inc. will collaborate with Bristol Myers Squibb Co. in a research collaboration and license agreement totaling $3.61 billion. The two companies plan ...

Prime Medicine and Bristol Myers Squibb are collaborating on next-generation ex vivo T-cell therapies. Read more here.

A federal court in New York has reportedly dismissed a $6.4B suit against Bristol Myers Squibb (NYSE:BMY) that alleged the ...

The man charged with attempting to assassinate Donald Trump after allegedly positioning himself with a rifle outside one of the former president's Florida golf courses on Sept. 15 pleaded not ...

Copyright 2024 The Associated Press. All Rights Reserved. People across the American Southeast stay resilient in the wake of Hurricane Helene Americans in the ...

Their stories come as the county is undergoing a public reckoning over child welfare policies ...